Peroxisome proliferator activated receptor-γ modulates reactive oxygen species generation and activation of nuclear factor-κB and hypoxia-inducible factor 1⍺ in allergic airway disease of mice - 17/08/11
, So Ri Kim, MD a, b, c, , Seoung Ju Park, MD a, b, c, Hee Sun Park, MD, PhD a, b, c, Kyung Hoon Min, MD a, b, c, Sun Mi Jin, BS b, c, Moon Kyu Lee, MD, PhD f, Uh Hyun Kim, MD, PhD d, e, Yong Chul Lee, MD, PhD a, b, c, ⁎ 
Reprint requests: Yong Chul Lee, MD, PhD, Department of Internal Medicine, Chonbuk National University Medical School, San 2-20, Geumam-dong, Jeonju, 561-180, Korea.Jeonju and Seoul, Korea
Abstract |
Background |
Reactive oxygen species (ROSs) play a crucial role in the pathogenesis of airway inflammation. Peroxisome proliferator activated receptor (PPAR)-γ is also involved in airway inflammation. We have demonstrated that the administration of PPARγ agonists or adenovirus carrying PPARγ cDNA (AdPPARγ) reduced bronchial inflammation and airway hyperresponsiveness. However, the effects of PPARγ on ROS generation in conditions associated with airway inflammation have not been clarified.
Objective |
This study aimed to investigate the effects of the PPARγ on ROS generation in allergic airway disease of mice.
Methods |
We have used a female C57BL/6 mouse model for allergic airway disease to determine the role of PPARγ.
Results |
In this study with an ovalbumin-induced murine model of allergic airway disease, the increased ROS generation and the increased expression of TH2 cell cytokines, adhesion molecules, chemokines, and vascular endothelial growth factor in lungs after ovalbumin inhalation were significantly reduced by the administration of PPARγ agonists or AdPPARγ. We also showed that the increased nuclear factor-κB and hypoxia-inducible factor 1⍺ levels in nuclear protein extracts of lung tissues after ovalbumin inhalation were decreased by the administration of PPARγ agonists or AdPPARγ.
Conclusion |
These results indicate that the effects of PPARγ are mediated by the modulation of ROS generation and activation of redox-sensitive transcription factor nuclear factor-κB and HIF-1⍺ in allergic airway disease of mice.
Clinical implications |
Thus, these findings provide a pivotal molecular mechanism for the use of PPARγ agonists to prevent and/or treat asthma and other airway inflammatory disorders.
Le texte complet de cet article est disponible en PDF.Key words : Asthma, HIF-1⍺, NF-κB, oxidative stress, peroxisome proliferator activated receptor γ
Abbreviations used : AdPPARγ, BAL, EBD, HIF, ICAM-1, NF-κB, PPAR, ROS, VCAM-1, VEGF
Plan
| Supported by grants from the National Research Laboratory Program and from the Medical Science and Engineering Research Center of the Korea Science and Engineering Foundation (R13-2002-038-01004-0), Republic of Korea. Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest. |
Vol 118 - N° 1
P. 120-127 - juillet 2006 Retour au numéro
Article précédent
- Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism
- Anick Langlois, Claudine Ferland, Guy M. Tremblay, Michel Laviolette
- Short course of systemic corticosteroids in sinonasal polyposis: A double-blind, randomized, placebo-controlled trial with evaluation of outcome measures
- Pravin Hissaria, William Smith, Peter J. Wormald, James Taylor, Mathew Vadas, David Gillis, Frank Kette
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?